9th Circ. Refuses To Revive Novartis Jaw Injury Suit

Law360, Los Angeles (February 20, 2014, 10:34 PM EST) -- A Ninth Circuit panel on Thursday refused to revive a product liability lawsuit against Novartis Pharmaceuticals Corp. over jaw injuries allegedly related to bone drugs Aredia and Zometa, ruling that the plaintiff continued the drugs after his injury and could not prove they caused it.

In a memorandum opinion, the court affirmed a lower court’s grant of summary judgment to Novartis because plaintiff Duane Luttrell could not prove the drugs were the proximate cause of his jaw’s osteonecrosis.

Luttrell claimed Novartis did not provide proper warning...
To view the full article, register now.




Case Information

Case Title

Duane Luttrell v. Novartis Pharmaceuticals Corp.

Case Number



Appellate - 9th Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

October 29, 2012

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.